Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2006-12-08FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for infliximab submitted by Janssen Biotech, Inc.
-
FDA approval · 2006-09-26FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., updating the drug's labeling.
-
CLINICAL_TRIALS research · 2006-09-21Clinical Trial Update: Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis [Phase 1, Phase 2]
This document describes an ongoing Phase 1/Phase 2 clinical trial evaluating a local PPARgamma ligand for distal ulcerative colitis; no resu…
-
CLINICAL_TRIALS research · 2006-09-11Clinical Trial Update: The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels [Phase 4]
This Phase 4 study examines how 5-aminosalicylates affect thiopurine metabolite levels in patients with Crohn's disease and ulcerative colit…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. [NA]
A completed clinical trial evaluated the combination of Lactobacillus rhamnosus and Lactobacillus acidophilus for ulcerative colitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-07-28FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited, likely to authorize a new contract manufactur…
-
CLINICAL_TRIALS trial_result · 2006-07-14Clinical Trial Update: Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia [Phase 3]
A completed Phase 3 trial evaluating chromoscopic guided endomicroscopy to diagnose colitis-associated dysplasia in ulcerative colitis patie…
-
FDA approval · 2006-06-27FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PENTASA (mesalamine) from Takeda Pharmaceuticals America, Inc., granting updated labeling an…
-
FDA approval · 2006-06-08FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for CANASA (mesalamine) submitted by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2006-05-18Clinical Trial Update: Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis [Phase 1]
A Phase 1 study evaluating rhIL-11 in left-sided ulcerative colitis was terminated. The sponsor Wyeth is now a wholly owned subsidiary of Pf…